{"id":"W1994978349","doi":"10.1186/1471-2407-8-195","title":"A single dose of pegfilgrastim compared with daily filgrastim for supporting neutrophil recovery in patients treated for low-to-intermediate risk acute myeloid leukemia: results from a randomized, double-blind, phase 2 trial","year":2008,"lang":"en","type":"article","venue":"BMC Cancer","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"Amgen","keywords":"Filgrastim; Pegfilgrastim; Medicine; Neutropenia; Cytarabine; Febrile neutropenia; Internal medicine; Chemotherapy; Induction chemotherapy; Myeloid leukemia; Surgery; Oncology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003296402,0.0003878848,0.001599729,0.0003447242,0.0001609173,0.00002628572,0.0001471909,0.0001549763,0.00005654183],"category_scores_gemma":[0.0003442883,0.0003072592,0.00045891,0.0004905033,0.0001690057,0.0001579523,0.00003788355,0.0002454729,0.000004183041],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006091091,"about_ca_system_score_gemma":0.0009823486,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004301542,"about_ca_topic_score_gemma":0.003370278,"domain_scores_codex":[0.9969595,0.000100873,0.001349942,0.0007132741,0.0003310842,0.0005453254],"domain_scores_gemma":[0.9971557,0.0007750372,0.0009392308,0.0004139914,0.0004607393,0.0002552499],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9850967,0.001152789,0.005252011,0.00008190468,0.0005394951,0.0000145108,0.000642202,0.001562292,0.001553551,8.122828e-7,0.002261798,0.001841913],"study_design_scores_gemma":[0.9779926,0.006087216,0.004218369,0.0004769741,0.001437625,0.000005558011,0.00004558747,0.001291696,0.007782404,0.00001538854,0.000314483,0.0003321088],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9821532,0.00004562271,0.001780185,0.00006909217,0.0006886452,0.01001531,0.005078388,0.00006433564,0.0001051815],"genre_scores_gemma":[0.9907283,0.0000943694,0.001608012,0.000112802,0.0006180056,0.004811638,0.001587356,0.00008087025,0.0003586264],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008575076,"threshold_uncertainty_score":0.999938,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04631734565704509,"score_gpt":0.3240688621418412,"score_spread":0.2777515164847961,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}